|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development |
| 1. |
Optimer Pharmaceuticals
|
|
|
Develops late-stage anti-infective and preclinical antibiotics by carbohydrate technology.
|
| 2. |
Maxygen, Inc.
|
|
|
Develops proprietary protein modifications including PEG, glycosylation and vaccines. Overview of technologies, clinical trial pipeline, investor data and careers in Redwood City, California. (Nasdaq: MAXY)
|
| 3. |
Xenova Group plc
|
|
|
Holding company for drug discovery subsidiaries, developing anti-cancer compounds in clinical stage, and addiction vaccines. Includes candidates for therapeutic focus, investor details, with contacts in Slough and Cambridge, England. (Nasdaq: XNVA)
|
| 4. |
BioSphings AG.
|
|
|
Development and marketing of products to treat viral infections, cancer and autoimmune diseases. Features product pipeline and company details. Frankfurt, Germany.
|
| 5. |
Novacta Biosystems Ltd.
|
|
|
Drug discovery and development company using pathway engineering and chemistry to optimise the activity of natural products for the treatment of infectious diseases. Introduces biotransformation technology, lead compounds, key personnel in Hatfield, England.
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
